Some people living with chronic stress have a higher risk of stroke, according to a new study. The study looked at younger adults and found an association between stress and stroke, with no known ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox ...

Some people living with chronic stress have a higher risk of stroke, according to a study published on March 5, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

Chronic stress could be a hidden stroke risk for younger women, according to new research. Scientists found that women aged 18 to 49 who reported moderate stress levels had a significantly higher ...

Ischaemic heart diseases, neoplasms and cerebrovascular diseases were the top three causes of death in the country from January to August of 2024, according to the Philippine Statistics Authority (PSA ...

The US Food and Drug Administration has approved Tenecteplase as first FDA-approved stroke medication in nearly three decades ...

Every year, millions of people die from stroke. In order to win against this disease which occurs the moment when a blood ...

A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

RHHBY's member company, Genentech, obtains FDA nod for TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.